The effect of a disease-specific supplement on the postprandial plasma glucose response in type 2 diabetic patients at baseline and after 6 and 12 weeks of supplementation.
Completed
- Conditions
- Type 2 diabetic patients in need of nutritional support.
- Registration Number
- NL-OMON23712
- Lead Sponsor
- umico Research B.V.P.O. Box 70056700 CA WageningenBosrandweg 206704 PH WageningenThe NetherlandsTel: +31 (0)317 467 800Fax: +31 (0)317 466 500
- Brief Summary
Diabetes Res Clin Pract. 2008 Apr;80(1):75-82. Epub 2007 Dec 11.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 34
Inclusion Criteria
1. Diagnosis type 2 diabetes;
2. Age > 18;
Exclusion Criteria
1. Pregnant or lactating woman or woman planning to become pregnant;
2. Usage of a disease specific nutritional supplement within past 4 weeks;
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Postprandial glucose response.
- Secondary Outcome Measures
Name Time Method 1. Glycaemic control before and after 6 and 12 weeks of supplementation;<br /><br>2. Fasting plasma lipid profile before and after 6 and 12 weeks of supplementation.